Form 4: Progyny Director Debra Morris Acquires Shares

Debra L. Morris, a Director at Progyny, Inc., has acquired shares and stock options through a transaction on May 21, 2026.

Summary

• Debra L. Morris, a Director at Progyny, Inc., acquired 5,660 shares of common stock on May 21, 2026, with no cost indicated.
• Morris also acquired stock options to purchase 3,203 shares of common stock at an exercise price of $24.69, with an expiration date of May 20, 2036.
• Additionally, Morris acquired another set of stock options for 27,119 shares of common stock at an exercise price of $24.69, also expiring on May 20, 2036.
• The restricted stock units (RSUs) underlying the first transaction vest on May 21, 2027, or the day before the company's first annual meeting after the grant date, contingent on continued service.
• The stock options acquired in lieu of an annual cash retainer vest under similar conditions as the RSUs.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating continued commitment from a director through equity awards, but without significant new financial performance data.

Positives

• Director Debra L. Morris has increased her beneficial ownership in Progyny, Inc. through the acquisition of common stock and stock options.
• The acquisition of stock options, particularly those granted in lieu of cash compensation, suggests a long-term alignment of management interests with shareholder value.
• The vesting schedules for the RSUs and stock options encourage continued service and commitment to the company's performance.

Negatives

• The filing does not provide details on the specific reasons for the acquisition beyond it being a grant or in lieu of compensation, which could be interpreted as a lack of proactive investment by the director.
• The exercise price of the stock options ($24.69) is significantly higher than the current market price, implying that these options may not be immediately in-the-money.

Risks

• The vesting of RSUs and stock options is contingent on continued service, meaning any departure from the company before the vesting date would result in forfeiture.
• The value of the acquired stock options is subject to market fluctuations and the future performance of Progyny, Inc.'s stock price.

Future Outlook

The future outlook for the acquired securities is dependent on the continued service of Debra L. Morris and the future performance of Progyny, Inc.'s stock price, with vesting scheduled for May 21, 2027, or the day before the company's first annual meeting of stockholders following the grant date.

Management Comments

• The stock options were issued to the Reporting Person in lieu of an annual cash retainer for board and committee service.
• The RSUs represent a contingent right to receive one share of Issuer common stock.

Industry Context

StockSavvy.ai notes that the acquisition of equity by a director, especially in lieu of cash compensation, is a common practice in the healthcare benefits management industry to align executive interests with long-term shareholder value.

Stakeholder Impact

• Shareholders: The acquisition of shares and options by a director can be viewed positively as it aligns management's interests with those of shareholders, potentially signaling confidence in the company's future performance.
• Employees: The compensation structure for directors, including equity awards, can influence overall compensation philosophies within the company.
• Management: The use of stock options in lieu of cash retainer reinforces the company's strategy of incentivizing long-term performance and retention.

Next Steps

• Vesting of RSUs and stock options on May 21, 2027, or the day before the Issuer's first annual meeting of stockholders following the grant date, subject to continued service.
• Potential exercise of stock options by Debra L. Morris after vesting, depending on market conditions and personal financial goals.

Key Dates

Keywords

Progyny, PGNY, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Director, Securities, SEC Filing, Beneficial Ownership